25 Apr 2019 | 10:18 AM
 

Cadila Healthcare Ltd. Share Price Live (BSE)
0

BSE Code: 532321 | NSE Symbol: CADILAHC
330.20
0.45
(0.14 %)
25 Apr 2019 | 10:16 AM
Change company
  • Open (Rs)
    329.85
  • Prev. close (Rs.)
    329.75
  • High (Rs.)
    331.20
  • Low (Rs.)
    329.60
  • 52W H (Rs.)
    431.00
  • 52W L (Rs.)
    308.55
  • Volume
    5612
  • MCap (Rs in Cr.)
    33,804.00
319
-0.70
(-0.22 %)
  • Open (Rs)
    322.70
  • High (Rs)
    323.30
  • Low (Rs)
    317.50
  • Prev. close(Rs)
    319.70
  • Contracts Tra.
    32,94,400
  • Turnover (Cr.)
    105
  • Open Interest
    19,80,800
  • Open Int. chg
    -28,89,600.00
1D| 1W| 1M | 3M | 6M | 1YR | MAX

Financials

EPS
17.35
Operating Margin (%)
24.11
Gross Profit Margin (%)
19.60
Net Profit Margin (%)
14.87
Total Debt/Equity
0.58
Dividend payout Ratio (Net Profit)
0.05
Earning Retention Ratio
99.95

News

07 Feb 2019 - 14:30:00-The company reported standalone net profit of Rs 363...
27 Nov 2018 - 15:10:00-Drug firm Zydus Cadila Tuesday said it has received final nod from the US health regulator to market...
22 Nov 2018 - 17:23:00-Drug maker Zydus Cadila Thursday said it has received approval from the US health regulator to marke...
20 Nov 2018 - 15:16:00-Drug firm Zydus Cadila Tuesday said it has received tentative nod from the US health regulator to ma...

Announcements

18-Apr-2019
Cadila Healthcar - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
17-Apr-2019
Cadila Healthcar - Press Release
17-Apr-2019
Cadila Healthcar - Announcement under Regulation 30 (LODR)-Press Release / Media Release
17-Apr-2019
Zydus Cadila gets USFDA nod for convulsive disorders treatment drug
12-Apr-2019
Cadila Healthcar - Updates

Religare Research

28 Feb 2019 | 10:15 AM
• Agri markets kept trading with high volatility with no strong directions, even as prices seem to f...
04 Feb 2019 | 11:57 AM
Agri Fundamental & Technical Report
21 Jan 2019 | 07:35 PM
Weekly report
07 Jan 2019 | 06:56 PM
Gold prices fell on Friday, pulling back from more than a six-month peak hit earlier in the session,...

Fund Interest

Schemes Shares Held Mkt. Value Latest Nav % Nav
10,00,405 189.90 98.75 0.88
10,00,405 189.90 28.32 0.88
10,00,405 189.90 98.75 0.88
10,00,405 189.90 103.58 0.89
10,00,405 189.90 36.69 0.89

Shareholding Pattern

       
Promotors74.79%
Mutual Funds/UTI5.31%
FI/Banks3.75%
Insurance3.75%
FII8.12%
Government0.13%
Others2.29%

Peer Group

Company Intraday Graph
 Abbott India Ltd.
7,865.65(0.41)
3280
 Sanofi India Ltd.
5,635.30(-0.72)
3325
 Pfizer Ltd.
3,137.00(-0.46)
3370
 Dr. Reddy`s Laboratories Ltd.
2,883.35(0.98)
3294

Exchange Information

NSE Index
Sensex
CNX 100
BSENAT
CNX 200
BSE200
CNX Bank
BSE500
CNX500
BSE Midcap
CNX Midcap
BSE Smallcap
Note: The scrip is a constituent of those NSE and BSE indices that have against them.

Company Indices

 1M (%)3M (%)6M (%)
Cadila Healthcare Ltd.-2.40-15.85-28.20
NIFTY(S&P CNX)399.40903.851,528.90
BSE SENSEX1,288.752,902.565,063.70
BSE 500469.451,002.841,807.90

Corporate Details

Key Personal
Ganesh N Nayak
Executive Director
Ganesh N Nayak
Whole Time Director & COO
Pankaj R Patel
Chairman
Key Address
Registered Office
Zydus Tower Satellite Cross Roads Sarkhej-Gandhinagar Highway,Ahmedabad,Gujarat

Tel:079-26868100 26868101 26868102 26868103-20, Fax:079-26862365 26862366

investor.grievance@zyduscadila.com
http://www.zyduscadila.com
Registrar Office
Link Intime India Pvt. Ltd.
Add. :Block No. 202 2nd Floor Akshay Complex Off. Dhole Patil Road Near Ganesh Temple